These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2009732)

  • 1. Acceptability of cholestyramine and colestipol formulations in three common vehicles.
    Ito MK; Morreale AP
    Clin Pharm; 1991 Feb; 10(2):138-40. PubMed ID: 2009732
    [No Abstract]   [Full Text] [Related]  

  • 2. Acceptability of cholestyramine or colestipol combinations with six vehicles.
    Shaefer MS; Jungnickel PW; Jacobs EW; Maloley PA
    Clin Pharm; 1987 Jan; 6(1):51-4. PubMed ID: 3816107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acceptability of resin therapy to patients attending a hospital lipid clinic.
    Iversen SA; Davidson D; Davidson C
    Br J Clin Pharmacol; 1995 Jul; 40(1):92-4. PubMed ID: 8527276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
    Faruqui AM; Thurmond MS; Wenger J; Wenger NK
    J Pak Med Assoc; 1981 Nov; 31(11):241-5. PubMed ID: 6802993
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of cholestyramine and colestipol on the absorption of diclofenac in man.
    al-Balla SR; el-Sayed YM; al-Meshal MA; Gouda MW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):441-5. PubMed ID: 7981930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercholesterolemia: new values, new strategies.
    Lueg MC; Anding RH
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):112-3, 116-7, 120-2. PubMed ID: 3080456
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
    Xydakis AM; Guyton JR; Chiou P; Stein JL; Jones PH; Ballantyne CM
    Am J Cardiol; 2004 Sep; 94(6):795-7. PubMed ID: 15374793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for hypercholesterolemia; standardization of cholesterol measurements.
    JAMA; 1990 Jan; 263(3):375-6. PubMed ID: 2294303
    [No Abstract]   [Full Text] [Related]  

  • 12. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061
    [No Abstract]   [Full Text] [Related]  

  • 13. New guidelines for managing hypercholesterolemia. National Cholesterol Education Program.
    McKenney JM
    Am Pharm; 1993 Jul; NS33(7):24-32. PubMed ID: 8342492
    [No Abstract]   [Full Text] [Related]  

  • 14. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
    Kinosian BP; Eisenberg JM
    JAMA; 1988 Apr; 259(15):2249-54. PubMed ID: 3127607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminium hydroxide and cholestyramine in the treatment of acute diarrhea.
    Pichaipat V; Pinyosamosorn R; Varavithya W
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():155-8. PubMed ID: 2659716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
    Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
    Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy in children and adolescents with familial hypercholesterolemia.
    Stein EA
    Prog Clin Biol Res; 1988; 255():273-80. PubMed ID: 3340641
    [No Abstract]   [Full Text] [Related]  

  • 19. Ask the Pharmacist.
    McGurrey E
    Am Pharm; 1992 Sep; NS32(9):24. PubMed ID: 1442550
    [No Abstract]   [Full Text] [Related]  

  • 20. New microporous cholestyramine analog for treatment of hypercholesterolemia.
    De Simone R; Conti F; Lovati MR; Sirtori M; Cocuzza E; Sirtori CR
    J Pharm Sci; 1978 Dec; 67(12):1695-8. PubMed ID: 722483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.